CEO Buys Loom Large as Northpointe Faces Its Earnings Test
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
NPB heads into its Q3 print today with the most striking signal sitting not in the options market or the borrow desk, but in the company's own filing cabinet.
The dominant fact in the positioning picture is the CEO's conviction buying. Chairman and Chief Executive Charles Williams made three open-market purchases in late August and early September, spending roughly $2.75 million at prices between $16.74 and $16.95, none of them under a pre-arranged 10b5-1 plan. Discretionary purchases of that size by the top executive, made well above the current price of $15.78, are the kind of signal institutional investors typically treat as meaningful. The stock has since fallen about 6% from those purchase levels, widening the gap between where the CEO bought and where the market is today.
The analyst picture broadly supports the bull case, though with trimmed ambitions. Piper Sandler maintained its Overweight rating earlier this month but cut its target from $21.50 to $20.00. Keefe, Bruyette & Woods made a similar move after the last earnings report, holding Outperform while stepping down to $21.00. The consensus target of $19.72 sits roughly 25% above the current price. Bears, meanwhile, point to the structural vulnerability of a mortgage-heavy bank: Northpointe relies on originating and selling residential loans into the secondary market, making earnings sensitive to rate moves and investor appetite. That model delivered ugly results in each of the two preceding quarters, with the stock falling around 8% and 10% on those earnings days before drifting further in the subsequent week.
FDIC call-report data from the Federal Deposit Insurance Corporation provides a factual backdrop, even if it has not yet been measured as a leading indicator of the company's reported figures. Total assets have risen for six consecutive quarters, reaching $7.53 billion through April 2026. Net loans and leases have also climbed for six straight quarters, to $6.78 billion over the same period. These are balance-sheet growth streaks, not earnings forecasts, but they confirm the business has been expanding even through recent turbulent prints.
Short interest and the borrow market add little drama to this setup. Short interest at 2.1% of the free float is low, and availability is exceptionally loose at roughly 2,700%, meaning there is far more stock available to borrow than is currently borrowed. Borrowing costs have eased about 22% over the past month to 0.61%. The lending market carries no meaningful squeeze dynamic heading into this print.
Ownership is concentrated and, for the most part, patient. Castle Creek holds nearly 13% of shares. Wellington and several insider-linked names each hold 8% to 11% stakes, all on passive 13G filings. Adage Capital lifted its stake from 5.2% to 7.5% earlier this year, a quiet addition from a quantitative long/short manager worth noting. All 13D/G positions are as last disclosed around the 5% threshold; holders dropping below that level may not file again.
The print will test whether Northpointe's mortgage origination engine can produce results consistent with its balance-sheet growth, and whether any recovery in the rate environment is showing up in margins at a level that justifies the CEO's conviction over the summer.
Stocks in this article
See the live data behind this article on ORTEX.
Open NPB on ORTEX →How this article was generated
- Generated
- 21 Oct 2026, 04:15
- Data as of
- 21 Oct 2026, 04:01
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.